BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 26545620)

  • 1. Functional characterization of multiple DICER1 mutations in an adolescent.
    Wu MK; de Kock L; Conwell LS; Stewart CJ; King BR; Choong CS; Hussain K; Sabbaghian N; MacRae IJ; Fabian MR; Foulkes WD
    Endocr Relat Cancer; 2016 Feb; 23(2):L1-5. PubMed ID: 26545620
    [No Abstract]   [Full Text] [Related]  

  • 2. A family with Sertoli-Leydig cell tumour, multinodular goiter, and
    Haley M; Bindal P; McAuliffe A; Vredenburgh J
    Curr Oncol; 2019 Jun; 26(3):183-185. PubMed ID: 31285663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. DICER1 mutations in a patient with an ovarian Sertoli-Leydig tumor, well-differentiated fetal adenocarcinoma of the lung, and familial multinodular goiter.
    Wu Y; Chen D; Li Y; Bian L; Ma T; Xie M
    Eur J Med Genet; 2014; 57(11-12):621-5. PubMed ID: 25451712
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [A family with a congenital DICER1 mutation].
    Altaraihi M; Pedersen J; Rossing M; Gedes AM; Wadt K
    Ugeskr Laeger; 2018 Jun; 180(25):. PubMed ID: 29938629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. DICER1 exons 25 and 26 mutations are rare in common human tumours besides Sertoli-Leydig cell tumour.
    Kim MS; Lee SH; Yoo NJ; Lee SH
    Histopathology; 2013 Sep; 63(3):436-8. PubMed ID: 23763383
    [No Abstract]   [Full Text] [Related]  

  • 6. Familial multinodular goiter and Sertoli-Leydig cell tumors associated with a large intragenic in-frame
    Apellaniz-Ruiz M; de Kock L; Sabbaghian N; Guaraldi F; Ghizzoni L; Beccuti G; Foulkes WD
    Eur J Endocrinol; 2018 Feb; 178(2):K11-K19. PubMed ID: 29187512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ovarian Sertoli-Leydig Cell Tumor with Elevated Inhibin B as a Cause of Secondary Amenorrhea in an Adolescent with Germ Line DICER1 Mutation.
    Luke AM; Moroney JW; Snitchler A; Whiteway SL
    J Pediatr Adolesc Gynecol; 2017 Oct; 30(5):598-600. PubMed ID: 28502826
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutiple DICER1-related lesions associated with a germline deep intronic mutation.
    Verrier F; Dubois d'Enghien C; Gauthier-Villars M; Bonadona V; Faure-Conter C; Dijoud F; Stoppa-Lyonnet D; Houdayer C; Golmard L
    Pediatr Blood Cancer; 2018 Jun; 65(6):e27005. PubMed ID: 29469200
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distinct somatic DICER1 hotspot mutations in three metachronous ovarian Sertoli-Leydig cell tumors in a patient with DICER1 syndrome.
    Garcia A; Desrosiers L; Scollon S; Gruner S; Reuther J; Gandhi I; Patil N; Fuller MY; Dai H; Muzny D; Gibbs RA; Bercaw-Pratt JL; Rao SL; Rainusso N; Fisher KE; Lin FY; Plon SE; Parsons DW; Roy A
    Cancer Genet; 2022 Apr; 262-263():53-56. PubMed ID: 35026696
    [No Abstract]   [Full Text] [Related]  

  • 10. Novel pathogenic variant of
    Rivera-Hernández A; Madrigal-González M; Mejía-Carmona L; Martínez-López I; Pérez-Hernández MG; Bernal-Manjarrez J; Luna-Vidal S; Reta-Guerrero S; Rodríguez-Florido MA; Balcázar-Hernández L
    J Pediatr Endocrinol Metab; 2023 Aug; 36(8):782-785. PubMed ID: 37307239
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The co-occurrence of an ovarian Sertoli-Leydig cell tumor with a thyroid carcinoma is highly suggestive of a DICER1 syndrome.
    Durieux E; Descotes F; Mauduit C; Decaussin M; Guyetant S; Devouassoux-Shisheboran M
    Virchows Arch; 2016 May; 468(5):631-6. PubMed ID: 26983701
    [TBL] [Abstract][Full Text] [Related]  

  • 12. DICER1 hotspot mutations in ovarian Sertoli-Leydig cell tumors: a potential association with androgenic effects.
    Kato N; Kusumi T; Kamataki A; Tsunoda R; Fukase M; Kurose A
    Hum Pathol; 2017 Jan; 59():41-47. PubMed ID: 27664536
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DICER1-related Sertoli-Leydig cell tumor and gynandroblastoma: Clinical and genetic findings from the International Ovarian and Testicular Stromal Tumor Registry.
    Schultz KAP; Harris AK; Finch M; Dehner LP; Brown JB; Gershenson DM; Young RH; Field A; Yu W; Turner J; Cost NG; Schneider DT; Stewart DR; Frazier AL; Messinger Y; Hill DA
    Gynecol Oncol; 2017 Dec; 147(3):521-527. PubMed ID: 29037807
    [TBL] [Abstract][Full Text] [Related]  

  • 14. DICER1 mutations in familial multinodular goiter with and without ovarian Sertoli-Leydig cell tumors.
    Rio Frio T; Bahubeshi A; Kanellopoulou C; Hamel N; Niedziela M; Sabbaghian N; Pouchet C; Gilbert L; O'Brien PK; Serfas K; Broderick P; Houlston RS; Lesueur F; Bonora E; Muljo S; Schimke RN; Bouron-Dal Soglio D; Arseneau J; Schultz KA; Priest JR; Nguyen VH; Harach HR; Livingston DM; Foulkes WD; Tischkowitz M
    JAMA; 2011 Jan; 305(1):68-77. PubMed ID: 21205968
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The oncogenic roles of DICER1 RNase IIIb domain mutations in ovarian Sertoli-Leydig cell tumors.
    Wang Y; Chen J; Yang W; Mo F; Senz J; Yap D; Anglesio MS; Gilks B; Morin GB; Huntsman DG
    Neoplasia; 2015 Aug; 17(8):650-60. PubMed ID: 26408257
    [TBL] [Abstract][Full Text] [Related]  

  • 16. DICER1 and FOXL2 Mutation Status Correlates With Clinicopathologic Features in Ovarian Sertoli-Leydig Cell Tumors.
    Karnezis AN; Wang Y; Keul J; Tessier-Cloutier B; Magrill J; Kommoss S; Senz J; Yang W; Proctor L; Schmidt D; Clement PB; Gilks CB; Huntsman DG; Kommoss F
    Am J Surg Pathol; 2019 May; 43(5):628-638. PubMed ID: 30986800
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Recurrent somatic DICER1 mutations in nonepithelial ovarian cancers.
    Heravi-Moussavi A; Anglesio MS; Cheng SW; Senz J; Yang W; Prentice L; Fejes AP; Chow C; Tone A; Kalloger SE; Hamel N; Roth A; Ha G; Wan AN; Maines-Bandiera S; Salamanca C; Pasini B; Clarke BA; Lee AF; Lee CH; Zhao C; Young RH; Aparicio SA; Sorensen PH; Woo MM; Boyd N; Jones SJ; Hirst M; Marra MA; Gilks B; Shah SP; Foulkes WD; Morin GB; Huntsman DG
    N Engl J Med; 2012 Jan; 366(3):234-42. PubMed ID: 22187960
    [TBL] [Abstract][Full Text] [Related]  

  • 18. DICER1 and FOXL2 mutations in ovarian sex cord-stromal tumours: a GINECO Group study.
    Goulvent T; Ray-Coquard I; Borel S; Haddad V; Devouassoux-Shisheboran M; Vacher-Lavenu MC; Pujade-Laurraine E; Savina A; Maillet D; Gillet G; Treilleux I; Rimokh R
    Histopathology; 2016 Jan; 68(2):279-85. PubMed ID: 26033501
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Moderately differentiated Sertoli-Leydig cell tumour: a hormone-secreting neoplasm associated with DICER1 syndrome.
    Khan S; Hodgson A
    Int J Gynecol Cancer; 2023 Dec; 33(12):1981-1982. PubMed ID: 37543372
    [No Abstract]   [Full Text] [Related]  

  • 20. DICER1 Mutations Are Consistently Present in Moderately and Poorly Differentiated Sertoli-Leydig Cell Tumors.
    de Kock L; Terzic T; McCluggage WG; Stewart CJR; Shaw P; Foulkes WD; Clarke BA
    Am J Surg Pathol; 2017 Sep; 41(9):1178-1187. PubMed ID: 28654427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.